Thailand’s Senate Public Health Commission moved decisively on Tuesday to address two converging crises threatening the nation’s healthcare stability: a looming drug shortage driven by global energy tensions and a chronic liquidity crunch leaving public hospitals unable to pay suppliers.
During a meeting at the Parliament on March 31, 2026, the Commission approved the formation of a working group tasked with drafting a new National Health Security Act. The legislative push aims to modernize the legal framework governing the country’s universal coverage scheme, but the immediate focus remained on practical survival measures for hospitals facing cash flow paralysis.
Mr. Sophon Manomaya, the Third Vice-Chairman of the Commission and head of the Subcommittee on Budget, Management, and Governance, led the discussion. He emphasized that the new bill is not just a bureaucratic update but a necessary adaptation to ensure the system remains sustainable and efficient amidst changing public health contexts.
However, the legislative timeline is long, and the pressure on hospitals is immediate. The Commission heard stark data from the Food and Drug Administration (FDA) regarding drug security. Whereas private sector inventories are currently sufficient for three to twelve months, the supply chain is fragile. Shortages of plastic packaging, driven by restrictions on imported petrochemical raw materials, are already creating bottlenecks.
The Commission outlined a “Watch List” for critical medications, including life-saving drugs, surgical supplies, and cancer treatments. If global conflict scenarios extend beyond three months, the FDA plans to present higher-level policy adjustments for reserve management. In the meantime, regulators are urging flexibility in procurement rules to allow hospitals to accept alternative packaging or raw materials without compromising quality verification.
The Liquidity Bottleneck
Beyond supply chain logistics, the financial health of the hospitals themselves is at risk. The Commission highlighted a severe delay in payments to pharmaceutical companies, with public hospitals accumulating debts overdue by 14 to 15 months. This backlog threatens to dry up the supply of essential medicines as manufacturers may hesitate to continue delivering without payment assurance.
To restore trust and ensure continuity, the Commission recommended accelerating debt repayment to protect the rights of existing contractors. They also proposed a significant transparency measure: a public Dashboard. This system would allow citizens and stakeholders to track drug inventory status in real-time, serving as an early warning system for shortages.
The intersection of these issues—legal reform, supply chain resilience, and financial solvency—suggests a systemic stress test for Thailand’s universal health coverage. The Commission’s move to formalize a drafting team indicates recognition that the current laws may not be agile enough to handle modern geopolitical and economic shocks.
What This Means for the System
Why is a new Health Security Act being drafted now?
The current legal framework is being reviewed to better integrate budget management and governance under the national health security system. The Commission aims to develop proposals that make the law more sustainable and efficient, aligning it with the country’s evolving public health context.
How do payment delays affect patients?
When hospitals owe suppliers for over a year, pharmaceutical companies may restrict future shipments. This can lead to shortages of essential medicines, directly impacting patient access to treatment, particularly for chronic conditions like cancer or requiring surgery.
What is the purpose of the Dashboard?
The proposed Dashboard is designed to elevate transparency. It would enable the public and relevant sectors to monitor drug inventory levels continuously, helping to anticipate and prevent drug shortages before they become critical.
As the working group begins its legislative drafting, the real test will be whether these structural changes can arrive rapid enough to support hospitals currently navigating the red zone of inventory, and finance.






